Indian Journal of Endocrinology and Metabolism

BRIEF COMMUNICATION
Year
: 2018  |  Volume : 22  |  Issue : 1  |  Page : 164--166

Metformin + Sodium-glucose Co-transporter-2 Inhibitor: Salutogenic Lifestyle Mimetics in a Tablet?


Sanjay Kalra1, Jubbin Jacob2, Manash P Baruah3 
1 Department of Endocrinology, Bharti Hospital, Karnal, Haryana, India
2 Department of Endocrinology, Christian Medical College, Ludhiana, Punjab, India
3 Department of Endocrinology, Excel Hospitals, Guwahati, Assam, India

Correspondence Address:
Sanjay Kalra
Department of Endocrinology, Bharti Hospital, Karnal, Haryana
India

Salutogenesis is an accepted approach for chronic disease management. Calorie restriction and exercise are two evidence based salutogenic interventions in diabetes treatment. Calorie restriction mimetics and exercise mimetics may be used as pharmacological tools to help manage diabetes in a sulutogenic manner. This article discusses the biochemical basis and pharmacology of metformin and sodium glucose cotransporter 2 inhibitors. It describes how a combination of these drugs can be used as a calories restriction and exercise mimetic, to help improve diabetes control.


How to cite this article:
Kalra S, Jacob J, Baruah MP. Metformin + Sodium-glucose Co-transporter-2 Inhibitor: Salutogenic Lifestyle Mimetics in a Tablet?.Indian J Endocr Metab 2018;22:164-166


How to cite this URL:
Kalra S, Jacob J, Baruah MP. Metformin + Sodium-glucose Co-transporter-2 Inhibitor: Salutogenic Lifestyle Mimetics in a Tablet?. Indian J Endocr Metab [serial online] 2018 [cited 2021 Sep 24 ];22:164-166
Available from: https://www.ijem.in/article.asp?issn=2230-8210;year=2018;volume=22;issue=1;spage=164;epage=166;aulast=Kalra;type=0